Legal Opinion
Moore v. Checkpoint Therapeutics, Inc.
District Court, S.D. New York
Decided May 19, 2025No. 1:24-cv-02613Unknown
1Opinion
UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK 24 Civ, 2613 (PAE) IN RE CHECKPOINT THERAPEUTICS SECURITIES LITIGATION OPINION & ORDER PAUL A. ENGELMAYER, Disirict Judge: Lead plaintiff Hamilton Bailey brings this putative class action under the federal securities laws against defendant Checkpoint Therapeutics, Inc. (“Checkpoint”), a biopharmaceutical company, and its CEO James F. Oliviero (collectively with Checkpoint, “defendants’”). The putative class consists of all persons (other than defendants) who purchased securities of Checkpoint between March 10, 2021 and December 15,…
2Cases cited70 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Tellabs, Inc. v. Makor Issues & Rights, Ltd.Supreme Court of the United States · 2007
- Basic Inc. v. LevinsonSupreme Court of the United States · 1988
- TSC Industries, Inc. v. Northway, Inc.Supreme Court of the United States · 1976
65 more not listed; retrieve them via the Exa API.